Castration-Resistant Prostate Cancer (CRPC) Therapeutics Market to Reach $9.5 Billion, Globally, by 2020. The market is segmented across various segments such as Chemotherapy, Hormonal Therapy, Immunotherapy and Radiotherapy.

Source: Click here